Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy
Background: Chemotherapy-induced nausea and vomiting (CINV) is a common and significant problem in children receiving chemotherapy. While 5-HT3 blockers are commonly used antiemetics, there is no consensus about choice among them. This study was planned to look for clinician preference for 5-HT3 blo...
Saved in:
Main Authors: | Rohan Bansal (Author), Sonam Agrawal (Author), Saurabh Kohli (Author), Kunal Das (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018) -
Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
by: Naohisa Yoshida, et al.
Published: (2019) -
Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
by: Zhou M, et al.
Published: (2015) -
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
by: Lorusso V
Published: (2016) -
A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
by: Dhurjoti Prosad Bhattacharjee, et al.
Published: (2010)